New drug approved in Scotland for MSPublished: 13 July 2021 People living in Scotland can now be prescribed Kesimpta (ofatumumab),  The Scottish Medicines Consortium (SMC) has recommended. It will be available for those who have relapsing-remitting multiple sclerosis (MS) who are experiencing relapses or have disease activity visible with an